Abstract
The purpose of this study was to implement a model of permanent oral health care for oncopediatric patients and to observe its effects on severe oral mucositis and subsequent treatment interruptions. We performed a quasi-experimental study in the Pediatric Department of Napoleão Laureano Hospital, in the city of João Pessoa, Brazil. A integrated oral care was implemented by a dentistry team for prevention of comorbidities, such as infections, oral pain, oral function maintenance, oral mucositis, and interventions for lesions due to severe oral mucositis. The oral comorbidities were compared before and after the implementation. The duration of severe oral mucositis (SOM) before and after the interventions and the interruptions in treatment due to SOM were the main outcome measures. Permanent oral health care reduced the duration of SOM and reduced pediatric chemotherapy interruptions due to SOM by 81.8%.
Conclusion: The permanent oral health care to offer to oncopediatric patients increased surveillance regarding oral comorbidities and reduced chemotherapy interruptions due to severe oral mucositis. This care plan could be adopted anywhere around the world.
What is Known: • Several studies on oral care for pediatric oncology patients, especially regarding both prevention of and treatment for oral mucositis during antineoplastic therapy, have been published. | |
What is New: • This study describes the benefits of permanent oral care with daily oral surveillance for pediatric patients, which reduced the duration of severe oral mucositis, increased surveillance and the efficiency in diagnostic for signs of oral mucositis, enabling early intervention, and decreased chemotherapy interruptions, contributing positively to the course of treatment. |
Similar content being viewed by others
Data Availability
The data and material used in this study are available for any consultation and analysis.
Abbreviations
- NLH:
-
Napoleão Laureano Hospital
- G1:
-
Pre-intervention group
- G2:
-
Intervention group
- SOM:
-
Severe oral mucositis
- OAG:
-
Oral Assessment Guide
- dmft:
-
Decayed, Missing, and Filled Teeth Index in deciduous teeth
- DMFT:
-
Decayed, Missing, and Filled Teeth Index in permanent teeth
References
Cheng KK, Ip WY, Lee V, Li CH, Yuen HL, Epstein JB (2017) Measuring oral mucositis of pediatric patients with cancer: a psychometric evaluation of Chinese version of the oral mucositis daily questionnaire. Asia Pac J Oncol Nurs 4:330–335. https://doi.org/10.4103/apjon.apjon_39_17
Ribeiro ILA, Limeira RRT, Castro RD, Bonan PRF, Valença AMG (2017) Oral mucositis in pediatric patients in treatment for acute lymphoblastic leukemia. Int J Environ Res Public Health 14:1468. https://doi.org/10.3390/ijerph14121468
Devi KS, Allenidekania A (2019) The relationship of oral care practice at home with mucositis incidence in children with acute lymphoblastic leukemia. Compr Child Adolesc Nurs 42:56–64. https://doi.org/10.1080/24694193.2019.1577926
Riley P, Glenny AM, Worthington HV, Littlewood A, Clarkson JE, McCabe MG (2015) Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. Cochrane Libr 12:1–10. https://doi.org/10.1002/14651858.CD011552.pub2
He M, Zhang B, Shen N, Wu N, Sun J (2018) A systematic review and meta-analysis of the effect of low-level laser therapy (LLLT) on chemotherapy-induced oral mucositis in pediatric and young patients. Eur J Pediatr 177:7–17. https://doi.org/10.1007/s00431-017-3043-4
Treister NS, London WB, Guo D, Malsch M, Verrill K, Brewer J, Duncan CA (2016) Feasibility study evaluating extraoral photobiomodulation therapy for prevention of mucositis in pediatric hematopoietic cell transplantation. Photomed Laser Surg 34:178–184. https://doi.org/10.1089/pho.2015.4021
Bardellini E, Amadori F, Schumacher RF, D’Ippolito C, Porta F, Majorana A (2016) Efficacy of a solution composed by verbascoside, polyvinylpyrrolidone (PVP) and sodium hyaluronate in the treatment of chemotherapy-induced oral mucositis in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 38:559–563. https://doi.org/10.1097/MPH.0000000000000669
Ribeiro ILA, Valença AMG, Bonan PRF (2015) Treatment of severe oral mucositis in a pediatric patient undergoing chemotherapy. RGO 63:467–471. https://doi.org/10.1590/1981-863720150003000143007
Ritwik P (2018) Oral health for patients with childhood cancers. The Ochsner J 4:351–357. https://doi.org/10.31486/toj.18.0061
Parra JJ, Alvarado MC, Monsalve P, Costa ALF, Montesinos GA, Parra PA (2019) Oral health in children with acute lymphoblastic leukaemia: before and after chemotherapy treatment. Eur Arch of Paediatr Dent 21:129–136. https://doi.org/10.1007/s40368-019-00454-4
Staudenmaier T, Cenzer I, Crispin A, Ostermann H, Berger K (2018) Burden of oral mucositis in stem cell transplant patients-the patients’ perspective. Support Care Cancer 26:1577–1584. https://doi.org/10.1007/s00520-017-4000-5
Yamada SI, Soutome S, Hasegawa T, Tojyo I, Nakahara H, Kawakami M, Hirose M, Fujita S, Komori T, Kirita T, Shibuya Y, Umeda M, Kurita H (2020) A multicenter retrospective investigation on the efficacy of perioperative oral management in cancer patients. Medicine 99:e19129. https://doi.org/10.1097/MD.0000000000019129
Ribeiro ILA, Silva SM, Limeira RRT, Bonan PRF, Valença AMG, Lima-Neto EA, Castro RD (2020) Differences between the oral changes presented by patients with solid and hematologic tumors during the chemotherapeutic treatment. J of Applied Oral Sci 28:e20190020. https://doi.org/10.1590/1678-7757-2019-0020
Costa RC, Bezerra PMM, Damascena LCL, Ribeiro ILA, Bonan PRF, de Sousa SA, Almeida LFD, Valença AMG (2020) Impact of saliva and cariogenic microbiota on the chemotherapy-induced oral mucositis in oncopediatric patients: a preliminary longitudinal study. Int J of Dent 20:1243953–1243958. https://doi.org/10.1155/2020/1243953
Damascena LCL, de Lucena NNN, Ribeiro ILA, Pereira TL, Lima-Filho LMA, Valença AMG (2020) Severe oral mucositis in pediatric cancer patients: survival analysis and predictive factors. Int J Environ Res Public Health 17:1235. https://doi.org/10.3390/ijerph17041235
Silva MFA, Melo AVG, Barbosa GN, Pereira JZ, Alves PM, Gomes DQC (2014) Evaluation of oral health status and quality of life of head and neck cancer patients after radiation therapy. Serbia Dent J 61:14–20. https://doi.org/10.2298/SGS1401014S
Vieira TC, Ribeiro ILA, Alves CV, Bonan PRF, Lima-Neto EA, Valença AMG (2017) Factors associated with health-related quality of life among children with cancer from the standpoint of patients and caregivers. J Public Health 25:371–377. https://doi.org/10.1007/s10389-017-0791-6
Vieira TC, Ribeiro ILA, Lima-Neto EA, Valença AMG (2015) Access to and satisfaction with oral health care from the perspective of pediatric cancer patients and their caregivers. Pesqui Bras Odontopediatria Clin Integr 15(1):171–181. https://doi.org/10.4034/PBOCI.2015.151.19
Pires HF, Bezerra PMM, da Silva VB, Ribeiro ILA, Serpa EPM, Sousa SA, Valença AMG (2020) Occurrence and severity of oral mucositis in brazilian pediatric cancer patients. Pesqui Bras Odontopediatria Clin Integr 20:e5621. https://doi.org/10.1590/pboci.2020.085
Cheng KKF, Chang AM, Yuen MP (2004) Prevention of oral mucositis in paediatric patients treated with chemotherapy: a randomized crossover trial comparing two protocols of oral care. Eur J of Cancer 40:1208–1216. https://doi.org/10.1016/j.ejca.2003.10.023
Carvalho MS, Andreozzi VL, Codeço CT, Campos DP, Barbosa MTS, Shimakura SE (2011) Survival analysis. Health theory and applications. 2 ed. Fiocruz: Rio de Janeiro.
Damascena L, Lucena N, Ribeiro I, Araujo T, Castro RD, Bonan P, Lima Neto E, Araújo Filho LM, Valença AMG (2018) Factors contributing to the duration of chemotherapy-induced severe oral mucositis in oncopediatric patients. Int J Environ Res Public Health 6:1153. https://doi.org/10.3390/ijerph15061153
Mattos RMA, Mendonça RMH, Aguiar SS (2020) Adherence to dental treatment reduces oral complications related to cancer treatment in pediatric and adolescent patients. Support Care Cancer 28:661–670. https://doi.org/10.1007/s00520-019-04857-3
Silva VCR, Silveira FMM, Monteiro MGB, Cruz MMD, Júnior DFC, Godoy GP (2018) Photodynamic therapy for treatment of oral mucositis: pilot study with pediatric patients undergoing chemotherapy. Photodiagnosis Photodyn Ther 21:115–120. https://doi.org/10.1016/j.pdpdt.2017.11.010
Ribeiro IA, Silva SM, Limeira R, Bonan PRF, Valença AMG, Lima Neto EA, Castro RD (2019) Differences between the oral changes presented by patients with solid and hematologic tumors during the chemotherapeutic treatment. J Appl Oral Sci 28:e20190020. https://doi.org/10.1590/1678-7757-2019-0020
Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P, for the Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO), Arany P, al-Azri AR, Blijlevens N, Hovan A, Fregnani E, Fulton J, Gueiros LA, Rouleau T, Coller JK, al-Dasooqi N, Wardill H, Ameringer S, Antunes HS, Bateman EH, Bektas K, Bensadoun RJ, ten Bohmer K, Brito-Dellan N, Castillo D, Chiang K, de Mooij C, Eilers J, Epstein J, Galiti D, Fall-Dickson JM, Gobbo M, Issa Hazboun H, Jensen SB, Johansen J, Joy J, Joy K, Kandwal A, Kataoka T, Keefe D, Loprinzi CL, Lubart R, Skripnik Lucas A, Majorana A, Mayo B, de Mooij C, Mori T, Nair RG, Nasr N, Nicolatou-Galitis O, Ottaviani G, Migliorati C, Pentenero M, Porcello L, Peterson D, Potting C, Raber-Durlacher J, van Sebille YZA, Soga Y, Sonis S, Stringer AM, Thorpe D, Tilly V, Tissing W, Toro JJ, Treister NS, Vaddi A, Weikel D, van de Wetering M, Zur E (2020) MASCC/ISOO Clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 126(19):4423–4431. https://doi.org/10.1002/cncr.33100
Elad S, Raber-Durlacher JE, Brennan MT, Saunders DP, Mank AP, Zadik Y, Quinn B, Epstein JB, Blijlevens NMA, Waltimo T, Passweg JR, Correa MEP, Dahllöf G, Garming-Legert KUE, Logan RM, Potting CMJ, Shapira MY, Soga Y, Stringer J, Stokman MA, Vokurka S, Wallhult E, Yarom N, Jensen SB (2015) Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer 23:223–236. https://doi.org/10.1007/s00520-014-2378-x
Qutob AF, Allen G, Gue S, Revesz T, Logan R, Keefe D (2013) Implementation of a hospital oral care protocol and recording of oral mucositis in children receiving cancer treatment. Support Care Cancer 21:1113–1120. https://doi.org/10.1007/s00520-012-1633-2
Anath P, Melvin P, Feudtner C, Wolfe J, Berry JG (2015) Hospital use in the last year of life for children with life-threatening complex chronic conditions. Pediatrics 136:938–946. https://doi.org/10.1542/peds.2015-0260
Allen G, Logan R, Revesz T, Keefe D, Gue S (2018) The prevalence and investigation of risk factors of oral mucositis in a pediatric oncology inpatient population: a prospective study. J Pediatr Hematol Oncol 40:15–21. https://doi.org/10.1097/MPH.0000000000000970
McCullough RW (2017) US oncology-wide incidence, duration, costs and deaths from chemoradiation mucositis and antimucositis therapy benefits. Future Oncol. 13:2823–2852. https://doi.org/10.2217/fon-2017-0418
McGrady ME, Ryan JL, Gutiérrez-Colina AM, Fredericks EM, Towner EK, Pai ALH (2015) The impact of effective paediatric adherence promotion interventions: systematic review and meta-analysis. Child Care Health Dev 41:789–802. https://doi.org/10.1111/cch.12271
Oliveira C, Bremner KE, Liu N, Greenberg ML, Nathan PC, McBride ML, Krahn MD (2017) Costs for childhood and adolescent cancer, 90 days prediagnosis and 1 year postdiagnosis: a population-based study in Ontario, Canada. Value Health 20:345–356. https://doi.org/10.1016/j.jval.2016.10.010
Amadori F, Bardellini E, Conti G, Pedrini N, Schumacher RF, Majorana A (2016) Low-level laser therapy for treatment of chemotherapy-induced oral mucositis in childhood: a randomized double-blind controlled study. Lasers Med Sci 31:1231–1236. https://doi.org/10.1007/s10103-016-1975-y
Code availability
In data analysis, we used the R software, a free software (R Core Team (2019) (R: A language and environment for statistical computing; R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.)).
Funding
The present study received a research grant from the World Health Organization Implementation Research Regional Training Centre for the Americas Region.
Author information
Authors and Affiliations
Contributions
ILA - concept, design, implementation of the care model, data collect, data analysis, article writing, and critical review.
AMGV - concept, design, implementation of the care model, data collect, data analysis, article writing, and critical review.
RDC - concept, design, implementation of the care model, article writing, and critical review.
RCC - implementation of the care model, data collect, and article writing.
LCLD - implementation of the care model, data collect, and article writing.
NNNL - implementation of the care model, data collect, and article writing.
PMMB - implementation of the care model, data collect, and article writing.
FGS - implementation of the care model, data collect, and article writing.
EMS - implementation of the care model, data collect, and article writing.
SAS - implementation of the care model, data collect, and article writing.
Corresponding author
Ethics declarations
Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals
All the patients consented to participate in this study or had their participation consented by the caregiver by signing the terms of consent and consent.
Ethics approval
This study was approved by the ethics committee on human research at the Health Sciences Center, Federal University of Paraíba (protocol number: 12922113.8.0000.5188) and conducted according to the ethical principles of the Declaration of Helsinki.
Consent to participate
All the patients consented to participate in this study or had their participation consented by the caregiver by signing the terms of consent and consent.
Consent for publication
N/A
Conflict of interest
The authors declare no competing interests.
Additional information
Communicated by Peter de Winter
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ribeiro, I.L.A., de Castro, R.D., Costa, R.C. et al. Integrated oral care contributes positively to the course of treatment of oncopediatric patients. Eur J Pediatr 180, 2757–2764 (2021). https://doi.org/10.1007/s00431-021-04024-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-021-04024-z